These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7540272)

  • 1. Differential regulation of adenylate cyclase activity in rat ventral and dorsal hippocampus by rat galanin.
    Valkna A; Juréus A; Karelson E; Zilmer M; Bartfai T; Langel U
    Neurosci Lett; 1995 Mar; 187(2):75-8. PubMed ID: 7540272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin inhibits adenylate cyclase of rat brain membranes.
    Chen Y; Laburthe M; Amiranoff B
    Peptides; 1992; 13(2):339-41. PubMed ID: 1384008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain.
    Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G
    Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus.
    Karelson E; Laasik J; Sillard R
    Neuropeptides; 1995 Jan; 28(1):21-8. PubMed ID: 7538201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.
    de Mazancourt P; Goldsmith PK; Weinstein LS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):369-75. PubMed ID: 7526840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus.
    Petrenko S; Olianas MC; Onali P; Gessa GL
    Eur J Pharmacol; 1987 Apr; 136(3):425-8. PubMed ID: 3609127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.
    Markstein R; Stöckli KA; Reubi JC
    Neurosci Lett; 1989 Sep; 104(1-2):13-8. PubMed ID: 2573010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell.
    McDermott AM; Sharp GW
    Diabetes; 1995 Apr; 44(4):453-9. PubMed ID: 7535266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
    Okada F; Tokumitsu Y; Nomura Y
    J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation and inhibition of rat basophilic leukemia cell adenylate cyclase by forskolin.
    Jakobs KH; Watanabe Y
    Biochim Biophys Acta; 1985 Sep; 846(3):356-63. PubMed ID: 3899183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
    De Vivo M; Maayani S
    Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
    Devivo M; Maayani S
    Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
    Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
    Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA(B) receptor-mediated stimulation of adenylyl cyclase activity in membranes of rat olfactory bulb.
    Olianas MC; Onali P
    Br J Pharmacol; 1999 Feb; 126(3):657-64. PubMed ID: 10188976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the spinal degradation products and inhibition of adenylate cyclase by recombinant rat galanin message-associated peptide.
    Andell-Jonsson S; Bartfai T
    Neuropeptides; 1998 Apr; 32(2):191-6. PubMed ID: 9639260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
    Mørk A; Geisler A
    Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.